Related Experiment Video
Updated: Dec 1, 2025

A Patient-Derived Xenograft Model for Venous Malformation
Published on: June 15, 2020
Potential Second-Hits in Hereditary Hemorrhagic Telangiectasia
Carmelo Bernabeu1, Pinar Bayrak-Toydemir2,3, Jamie McDonald3,4
1Centro de Investigaciones Biológicas Margarita Salas, Consejo Superior de Investigaciones Científicas (CSIC) and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 28040 Madrid, Spain.
Hereditary hemorrhagic telangiectasia (HHT) is a genetic disorder caused by mutations in specific genes. Research suggests a "second-hit" mechanism, involving various triggers, is necessary for developing vascular lesions in HHT patients.
Area of Science:
- Genetics
- Vascular Biology
- Pathophysiology
Background:
- Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disorder characterized by mucocutaneous telangiectases and internal arteriovenous malformations (AVMs).
- Mutations in *ENG*, *ACVRL1*, and *MADH4* genes are responsible for over 95% of HHT cases.
- The focal and variable presentation of vascular lesions suggests a "second-hit" hypothesis beyond HHT gene heterozygosity.
Purpose of the Study:
- To review and summarize the various triggers (second-hits) implicated in the development of vascular lesions in HHT.
- To elucidate the functional mechanisms by which these triggers interact with HHT gene heterozygosity.
Main Methods:
- Literature review of research on HHT pathogenesis.
- Analysis of postulated "second-hit" factors and their proposed mechanisms.
Main Results:
- Identified multiple postulated "second-hits" including mechanical trauma, light, inflammation, vascular injury, angiogenic stimuli, shear stress, modifier genes, and somatic mutations.
- These triggers are hypothesized to synergize with HHT gene heterozygosity to initiate lesion formation.
Conclusions:
- HHT pathogenesis likely involves a multi-step process requiring both an inherited HHT gene mutation and a subsequent "second-hit" event.
- Understanding these triggers and mechanisms is crucial for developing targeted therapies for HHT.
More Related Videos
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Mechanism of Angiogenesis
Anticoagulant Drugs: Low-Molecular-Weight Heparins
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

